Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis

Daniel J. Deangelo, Ruben A. Mesa, Warren Fiskus, Ayalew Tefferi, Carole Paley, Martha Wadleigh, Ellen K. Ritchie, David S. Snyder, Kebede Begna, Siddhartha Ganguly, Michael S. Ondovik, Jessica Rine, Kapil N. Bhalla

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences